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Abstract
The regulation of gene transcription requires posttranslational modifications of histones that, in concert with chromatin
remodeling factors, shape the structure of chromatin. It is currently under intense investigation how this structure is
modulated, in particular in the context of proliferation and differentiation. Compelling evidence suggests that the
transcription factor NF-Y acts as a master regulator of cell cycle progression, activating the transcription of many cell cycle
regulatory genes. However, the underlying molecular mechanisms are not yet completely understood. Here we show that
NF-Y exerts its effect on transcription through the modulation of the histone ‘‘code’’. NF-Y colocalizes with nascent RNA,
while RNA polymerase II is I phosphorylated on serine 2 of the YSPTSPS repeats within its carboxyterminal domain and
histones are carrying modifications that represent activation signals of gene expression (H3K9ac and PAN-H4ac). Comparing
postmitotic muscle tissue from normal mice and proliferating muscles from mdx mice, we demonstrate by chromatin
immunoprecipitation (ChIP) that NF-Y DNA binding activity correlates with the accumulation of acetylated histones H3 and
H4 on promoters of key cell cycle regulatory genes, and with their active transcription. Accordingly, p300 is recruited onto
the chromatin of NF-Y target genes in a NF-Y-dependent manner, as demonstrated by Re-ChIP. Conversely, the loss of NF-Y
binding correlates with a decrease of acetylated histones, the recruitment of HDAC1, and a repressed heterochromatic state
with enrichment of histones carrying modifications known to mediate silencing of gene expression (H3K9me3, H3K27me2
and H4K20me3). As a consequence, NF-Y target genes are downregulated in this context. In conclusion, our data indicate a
role of NF-Y in modulating the structure and transcriptional competence of chromatin in vivo and support a model in which
NF-Y-dependent histone ‘‘code’’ changes contribute to the proper discrimination between proliferating and postmitotic
cells in vivo and in vitro.
Citation: Gurtner A, Fuschi P, Magi F, Colussi C, Gaetano C, et al. (2008) NF-Y Dependent Epigenetic Modifications Discriminate between Proliferating and
Postmitotic Tissue. PLoS ONE 3(4): e2047. doi:10.1371/journal.pone.0002047
Editor: Laszlo Tora, Institute of Genetics and Molecular and Cellular Biology, France
Received September 27, 2007; Accepted March 13, 2008; Published April 23, 2008
Copyright:  2008 Gurtner et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work has been supported by grants to GP from Associazione Italiana Ricerca sul Cancro (AIRC), Ministero della Sanita’ (ICS-120.4/RA00-90; R.F.02/
184) and Istituto Superiore di Sanita’ (N.ACC2/R7.5). MD’s work was supported by the EU 6th Framework Program (Integrated Project Active p53), the German
Research Foundation (DFG), the German Cancer Aid/Dr. Mildred Scheel Stiftung, and the Wilhelm Sander Stiftung. CG’s work has been supported by: FIRB #
RBLA035A4X-1-FIRB, AIRC regional grant, UE FP6 grant # UE-LHSB-CT-04-502988 and AFM grants # MNM2-06 and #DdT2-06.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: piaggio@ifo.it
Introduction
A major question in biology today is how the chromatin
environments are interrelated with the machinery that drives
transcription, and how this impacts on biological processes. It is
well known that the covalent modifications in the N-terminal tails
of histones represent a key mechanism of transcriptional control in
all eukaryotic cells, and that the functional link between chromatin
structure and transcriptional activation is determined by the
histone ‘‘code’’. Two major players of this code consist in
acetylation and methylation of specific lysine residues within
histones H3 and H4 [1–4]. Generally, hyperacetylation correlates
with transcriptional activation, while methylation of specific lysines
is associated either with transcriptional repression or with
activation [1,5–7]. The enzymes that catalyze these transitions
are histone acetyltransferases (HATs), histones deacetylases
(HDACs) and histone methyltransferases (HMTs), respectively
[8]. It seems clear that transcription factors, chromatin remodel-
lers and histone modification enzymes work together to guide the
cell through cell cycle and differentiation as well as cell
transformation [1,9–12]. Many transcriptional co-activators and
co-repressor complexes with histone-modifying activities bind
transcription factors in vivo, suggesting that targeted chromatin
remodeling may be important for the function of transcription
factors [13,14]. Moreover, transcription factors like Myc, E2F, p53
and Rb are implicated in chromatin remodeling [15–20].
Based on these evidences, we investigated whether the
transcription factor NF-Y exerts its activity as a master regulator
of cell cycle progression, actively regulating the histone ‘‘code’’.
The histone-like transcription factor NF-Y is composed of three
highly conserved subunits, NF-YA, -YB, and -YC, all required for
binding of target sequences (CCAAT-boxes). NF-YA contains a
transactivation domain at the N-terminus, whereas its DNA
binding domain and the regions of interaction with NF-YB and
NF-YC are located at the C-terminal portion of the protein
[22,23]. NF-Y supports basal transcription of several cell cycle
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cdc25C, chk2, dhfr, topoisomerase IIalpha,a n dmdr-1, during different
phases of the cell cycle and in response to DNA damage [16,24–34].
In agreement with this, recent in silico studies point to NF-Y as a
common transcription factor for an increasing number of cell cycle
control genes [35,36]. These findings strongly support the concept of
the NF-Y complex as a key player in the regulation of proliferation
and viability. It has been reported that the expression of a dominant
negative NF-Y mutant blocks cell cycle progression in G1 and G2
[26,37]. Most importantly, the knock out of the NF-YA subunit in
mice leads to embryo lethality [38]. Recently, it has been suggested
that NF-Y may modulate transcription via histone acetylation
because of its interaction with the histone acetyl transferases p300/
CBP and GCN5/PCAF [16,27,39–42]. In reporter gene assays,
p300 enhances NF-Y-dependent transcription [43]. ChIP experi-
ments have shown that NF-Y and p300 are dynamically bound to
target promoters in the different phases of the cell cycle [16,44].
However, it is not known whether NF-Y directly recruits HATs to
chromatin, whether NF-Y leads to chromatin remodeling of its
target promoters, and whether NF-Y acts upstream rather than
downstream of histone tail modifications.
The data presented here clearly support the model of a direct
role for NF-Y in chromatin remodeling in vivo. NF-Y binding leads
to local histone hyperacetylation and correlates with hypo-
methylation, while NF-Y target genes are actively transcribed.
Local histone acetylation correlates with the recruitment of p300
and NF-Y. Loss of NF-Y binding, as induced by overexpressing a
dominant-negative NF-Y protein, inhibits the activity of its target
promoters and leads to local enrichment of methylated histones.
Most notably, in terminally differentiated cells and muscle tissue,
where NF-Y DNA binding is absent [45], NF-Y target genes
exhibit a repressed heterochromatic state with the typical
enrichment of H3K9me3, H4K20me3 and HP1a, and their
expression levels are reduced. By contrast, in muscles from mdx
mice, a murine model of human Duchenne muscular dystrophy
with high rate of proliferating cells, NF-Y is expressed and binds its
target promoters. In this system, NF-Y target genes are actively
transcribed, and their promoters have an open chromatin
structure. In conclusion, our data demonstrate that NF-Y regulates
epigenetic modifications, and the NF-Y-dependent histone ‘‘code’’
changes contribute to the discrimination between a proliferative
and a postmitotic status of the cells in vivo.
Results
NF-Y co-localizes with nascent mRNA and a transcription-
permissive histone ‘‘code’’
The involvement of NF-Y in transcription has been thoroughly
reported. In agreement with this, we show in Figure 1A that in the
nuclei of living cells, the NF-Y transcription factor colocalizes with
nascent RNA Polymerase II (RPII)transcripts. We used a technique
based on the incorporation of BrUTP into nascent RNA
predominantly transcribed by RPII in living cells (run-on).
Proliferating HeLa cells were transfected with BrUTP for 59 at
4uC and then incubated for 59 at 37uC; in this condition, most of the
BrUTP-labeled RNA is still nascent [46]. After fixation, nascent
RNA and endogenous NF-Y were visualized in a double-labeling
experiment by Confocal Laser Scanning Microscopy, using
antibodies against BrUTP and the NF-YA subunit, respectively.
The anti BrUTP signal exhibited the typical distribution pattern of
small spots which predominantly represent regions transcribed by
RPII [46] (Figure 1A, panel i). Of note, a large amount of NF-YA
(panel ii) colocalizes with nascent RNA (panel iii). Similar results
have been obtained with an antibody against the NF-YB subunit
Figure 1. (A) NF-Y is associated with active transcription sites
in living cells. After in vivo incorporation of BrUTP (run-on),
cells were fixed and endogenous NF-YA (ii) and nascent RNA
transcripts (i) were detected by indirect immunofluorescence
combined with Confocal Scanning Laser Microscopy by using
anti-NF-YA and anti-BrU antibodies. In the overlay (iii), yellow
indicates colocalizations between NF-YA (green) and transcription sites
(red). In panels vi and x cells were immunostained with anti-NF-YA, in
panels v and ix with anti-RPII CTD repeat YSPTSPS (phospho S2) and
anti-total RPII respectively. The majority of NF-YA (red) colocalizes with
the activated form of RPII (green)(vii). (B) Cells were immunostained
with anti-NF-YA (vii-xii), -acetylated H3K9 (i), -acetylated H4 (ii), -tri-
methylated H3K9 (iii), -di-methylated H3K27 (iv), -tri-methylated H4K20
(v) and -NF-YB (vi) antibodies. The majority of NF-YA colocalizes with
acetylated (xiii, xiv), but poor colocalization occurs with methylated
histones (xv, xvi,xvii). Panel xviii shows the overlay of two subunits of
NF-Y, NF-YA (xii) and NF-YB (vi). Panels from xix to xxiv represent a
typical optical field of the merge. In figure 1A and 1B confocal analysis
of single optical section is shown. The images have been collected with
a 60x objective.
doi:10.1371/journal.pone.0002047.g001
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transcriptionally active RPII complexes, we used an antibody
directed against the RPII protein phosphorylated at the serine 2
residue of the consensus repeat (Y1S2P3T4S5P6S7) contained in its
carboxyterminal domain (CTD), the transcriptionally active form of
RPII [47] (Figure 1A, panel v). In agreement with the results of the
run-on, we found a significant colocalization (panel vii) between
RPIIS2 (panel v) and NF-YA (panel vi). Since it is known that this
phosphorylation occurs during transcriptional elongation, these
results, together with the localization of NF-YA at nascent RNA ,
strongly support the notion that NF-Y is present at active
transcription foci. As a control, we also show the colocalization
(panel xi) of NF-YA (panel x) with total RPII (panel ix). Next, we
asked whether NF-Y colocalizes with post-translational modifica-
tions on histones that are known as positive marks of transcription.
Figure 1B shows that the majority of NF-YA (panels vii-xii)
colocalizes (panels xiii, xiv) with the transcription permissive histone
modifications H3K9ac and PAN-H4ac (panel i and ii), while poor
colocalization is observed with marks of close chromatin confor-
mation, H3K27me2 (panel iv) and H4K20me3 (panel v). NF-YA
weakly colocalized (panel xv) with H3K9me3 (panel xv). As a
positive control, the colocalization of NF-YA and -YB subunits is
shown (Figure 1B, panel xviii). Interestingly, we observed that NF-
YA could alsolocalizedinto thenucleoli.Thisresult is inagreement
with our previous observations with endogenous and exogenous
overexpressed NF-YA (G.P. personal observation). The amount of
NF-YA in the nucleoli is variable, being more detectable in some
cells (Figure 1A, panels vi and x) then in others (Figure 1B, panels
xiii-xviii). We never observed a completed exclusion of this protein
from the nucleoli, thus it will be interest in the future investigate
which could be the meaning of NF-YA nucleolar localization.
Taken together, these results indicate a direct interaction between
NF-Y and actively transcribed chromatin regions with an open
chromatin structure.
NF-Y binding correlates with a euchromatic
conformation of its target promoters
In order to study the role of NF-Y binding activity in histone
modifications at multiple genomic loci, we performed ChIP
experiments in proliferating (P) and terminally differentiated (TD)
C2C12 skeletal muscle cells. This cells line is a very useful
physiological system to study the relationship between NF-Y and
the mitotic status. Indeed, when C2C12 cells are actively
proliferating, NF-Y serves as a common transcription factor for
several key cell cycle control genes, and when cells are induced to
differentiate in myotubes, upon growth factors withdrawal, a
permanent down regulation of NFY-A expression leads to the
inhibition of NF-Y binding to its target promoters [45]. Consistent
with these findings, ChIP analysis demonstrates that in P cells, NF-
Y is recruited onto all tested promoters (Cyclin A2, Cyclin B1, Cyclin
B2, Cdk1, Cdc25C, Dhfr, Topoisimerase II a, Tk) (Figure 2A, lane 2).
This binding is associated with the presence of RPII (Figure 2A,
upper panel, lane 1) and the transcription permissive histone
marks H3K9ac and PAN-H4ac (lanes 3 and 4). Moreover, the
chromatin of NF-Y target promoters is characterized by low levels
of the heterochromatin marks H3K9me3 and H4K20me3 (lanes 5
and 6) [48], and the heterochromatin protein 1 (HP1a) (lane 7). In
contrast, in TD cells, the lack of NF-Y binding (Figure 2A, lower
panel, lane 2) correlates with the lack of RPII binding (lane 1) and
the induction of H3K9me3 and H4K20me3 (lanes 5 and 6). The
presence of methylated histones is accompanied by the recruit-
ment of heterochromatin protein 1 (HP1) (lane 7), a chromodo-
main protein that specifically recognizes H3K9me3 [49] and is
thought to be involved in organizing a higher-order chromatin
structure [48]. In agreement with this, NF-Y target cell cycle
regulatory genes are not transcribed in TD cells (Figure 2D, lane
2). We did not observe a substantial reduction in the association of
PAN-H4ac and H3K9ac with NF-Y target promoters in TD cells.
The pattern of acetylated and methylated histones is different
when we analyze the Myogenin promoter (Figure 2A, upper and
lower panel). This promoter is not bound by NF-Y (Figure 2A,
lane 2) and is actively transcribed in TD cells (Figure 2D, lane 2).
We extend these observations to primary myoblasts, which are
the proliferating progenitors of myotubes. These cells were
obtained from skeletal muscles of newborn mice and maintained
in culture in the presence of high serum concentration and basic
fibroblast growth factor (bFGF) to promote proliferation and
prevent differentiation. Muscle differentiation was induced by
serum withdrawal [50]. In this cell system, we performed ChIP
experiments followed by Q-PCR analysis (Q-ChIP). Also in
primary myoblasts, as well as in P C2C12 cells, the transcription
permissive histone marks H3K9ac and PAN-H4ac are associated
with NF-Y target promoters (Figure 2, panel B). Again, this
chromatin is characterized by low levels of the heterochromatin
marks H3K9me3, H4K20me3, H3K27me2, and pHP1a.I n
contrast, in myotubes, the chromatin of NF-Y target promoters
strongly associates with H3K9me3, H4K20me3, H3K27me2 and
pHP1a . Although we did not observe a substantial reduction in
the association of PAN-H4ac with NF-Y target promoters in
myotubes, the association of H3K9ac is strongly reduced. The
pattern of acetylated and methylated histones is different if we
analyze the promoters of two muscle genes that are not regulated
by NF-Y, Myogenin and Myosin Light Chain (MLC) (Figure 2C). All
together, these results suggest that, both in culture and in primary
muscle cells, the association of NF-Y with CCAAT boxes
correlates with hyperacetylation of histones H3 and H4; in
contrast, the absence of NF-Y binding to promoters of cell cycle
regulatory genes correlates with a local recruitment of hetero-
chromatic markers, such as H3K9me3, H4K20me3.
NF-Y recruits p300 onto its target promoters
We and others, have previously reported that the HAT p300
enzyme binds NF-Y target promoters, and that its binding
correlates with the presence of highly acetylated histones. Notably,
HDAC1 recruitment is inversely correlated to that of p300,
[16,43,44]. From the results obtained until now, we hypothesize
that NF-Y might control the transcription of its target genes
through local recruitment of histone-modifying enzymes. There-
fore, we performed experiments to verify whether NF-Y might
recruit the p300 enzyme onto its target promoter sequences and
consequently allows specific recruitment of acetylated histones.
First, we investigated the colocalization pattern of NF-Y and p300
or HDAC1 (Figure 3A).. As expected, NF-YA (panel ii) colocalizes
(panel iii) with p300 (panel i), while poor colocalization (panel vii)
is observed between NF-YA (panel vi) and HDAC1 (panel v).
Re-ChIP experiments offer an ideal means to test whether NF-
Y and p300 are co-recruited onto CCAAT containing promoters.
With the first ChIP, performed with antibodies against NF-YA,
-YB and p300 proteins, we observed that, as expected, NF-Y and
p300 are recruited on the same regions of Cdk1, Cdc25C, Cyclin A,
and Cyclin B2 promoters (Figure 3B, lane 1,2,3). After we
performed Re-ChIP analysis, immunoprecipitating the NF-YA-
containing complexes with an antibody against p300, only those
DNA sequences that are simultaneously bound by both proteins
would be amplified in the subsequent PCR. Our results show that
p300 and NF-Y are co-recruited at the same time on the same
DNA fragments (Figure 3B, lane 5) and suggest that the two
factors co-occupy common target loci. As expected, NF-YA and
NF-Y and Chromatin Remodeling
PLoS ONE | www.plosone.org 3 April 2008 | Volume 3 | Issue 4 | e2047Figure 2. Histone acetylation correlates with NF-Y recruitment onto its target promoters. (A) ChIPs performed on proliferating (P) and
terminally differentiated (TD) C2C12 cells using the indicated antibodies. No antibody was used as control (No Ab). (B) Q-ChIP analysis on
proliferating (P) and terminally differentiated (TD) primary myoblasts, performed with the indicated antibodies. The promoters analyzed were: 1)
CyclinA2, 2) CyclinB1,3 )CyclinB2, 4) Cdk1,5 )Cdc25C, 6) Dhfr, 7) TopoisomeraseIIa, 8) Tk. (C) Q-ChIP analysis of the Myogenin and MLC promoters
performed with the indicated antibodies on proliferating (P) and terminally differentiated (TD) primary myoblasts. On B and C the enrichment of
immunoprecipitated promoter fragments relative to the input was done. Rabbit IgG was used as control. (D) RT-PCR amplification of indicated genes
was performed on proliferating (P) and terminal differentiated (TD) C2C12.
doi:10.1371/journal.pone.0002047.g002
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p300 Re-ChIP signals were not due to a non specific background,
since when the NF-YA-containing complexes were subjected to a
second immunoprecipitation without antibody, no DNA was
immunoprecipitated (lane 6).
To assess whether the presence of NF-Y is required for p300
recruitment, we performed ChIP experiments on a mixed
population of cells stably transfected with a cyclin B2 promoter
carrying mutated CCAAT-boxes, linked to a luciferase gene
(pmut-CCAATCyclinB2-LUC). As expected, NF-Y does not bind
the mutated consensus sequences, as previously reported [24,49].
Of note, we observed that p300 is not recruited onto this DNA
(Figure 3B, lane 3), and accordingly, no signals in Re-ChIP
experiments were detected (Figure 3B, lanes 4 and 5). We quantify
these results by Q-Re-ChIP analysis performed on P and TD
C2C12 cells (Figure 3C). Although at different extent, we confirm
that NF-Y and p300 are co-recruited on several NF-Y target
promoters. As expected, no recruitment of p300 is observed in TD
C2C12 cells, where NF-Y is not expressed. In agreement with this,
by Q-ChIP analysis performed on murine muscle tissue
(Figure 3D), we observed that the absence of NF-Y binding on
its target promoters is associated with the absence of p300
recruitment. Notably, also in murine muscle tissue, as observed in
different cell lines (16, 43, 44, AG unpublished data), HDAC1
recruitment is inversely correlated to that of p300. (Figure 5 D)
The results shown here strongly support a direct role of NF-Y on
the p300 recruitment to the NF-Y targets we have analyzed. Of
note, the loss of p300 recruitment in the absence of NF-Y binding
is a common feature of both cell cultures (C2C12) and murine
muscle tissue, supporting its relevance in animals.
Loss of NF-Y binding allows recruitment of methylated
histones
In order to further address the direct role of NF-Y in chromatin
remodeling, we overexpressed in mouse embryo fibroblasts a
Figure 3. NF-Y recruits p300 onto its target promoters. (A) Cells were immunosteined with anti-NF-YA (ii, vii), anti-p300 (i), anti-HDAC1 (v)
antibodies. Panels iii and vii show the overlay of two proteins, panels iv and viii represents a typical optical field of merge. Confocal analysis of single
optical section is shown. (B) ChIPs and re-ChIPs experiments performed with anti-NF-YA, -NF-YB and –p300 antibodies, on proliferating C2C12 cells
and stable transfected C2C12 with pmut-CCAATcyclinB2-LUC vector. PCR analysis were performed on the immunoprecipitated DNA samples using
specific primers for the indicated promoters and specific primers for the exogenous cyclin B2 mutated promoter. No antibody was used as control
(No Ab). (C) Q-Re-ChIP analysis performed on proliferating (P) and terminally differentiated (TD) C2C12 cells using the indicated antibodies on the
sames promoters of panel B. (D) Q-ChIP experiments performed with anti-NF-YA, –p300 antibodies, using chromatin prepared from adductor
muscles of wt (white bars) and mdx (black bars) of C57BL/10 mice. Specific primers for Cdk1, Cyclin A2, Cyclin B2 and MLC promoters. The values
represent the mean of five indipendent experiments performed on triplicate.
doi:10.1371/journal.pone.0002047.g003
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molecule is a NF-YA protein with a triple amino acid substitution
in the DNA binding domain that impairs its ability to bind DNA.
It is still able to interact with a NF-YB/-YC dimer, but the
resulting trimer is inactive in terms of CCAAT recognition [52].
First, we investigated whether DN-NF-YA affects the expression of
NF-Y target genes. RT-PCR analysis performed 24 hours post
infection with an adenovirus vector expressing DN-NF-YA (Ad-
DN-NF-YA) shows that cyclin A2, B2, cdk1, cdc25C, topoisom-
erase IIa mRNAs were greatly down-regulated (Figure 4A, lane 3).
The cell cycle gene expression is only transiently repressed in the
presence of DN-NF-YA, as indicated by RT-PCR analysis
performed 48 hours after infection (Figure 4A, lane 4). The
transient effect observed might be attributed to the short half-life of
the mutant protein whose expression 48 hours after infection is
strongly reduced (Figure 4B, lane 3). Next, we investigated the
DNA recruitment of NF-Y, p300 and different histone post-
translational modifications after transduction with the adenovirus
vector expressing DN-NF-YA . Q-Chip analysis shows that,
although to different extents, the overexpression of DN-NF-YA
leads to a decrease in the recruitment of NF-Y to Cyclin B2, A2,
Cdk1, Cdc25C, Topoisomerase IIa, and Dhfr promoters at 16 and
24 hours post transduction (Figure 4C). Of note, the decrease of
NF-Y DNA binding activity caused a strong increase of H3K9me3
and H4K20me3, with a peak at 24 hours, while it caused only a
partial reduction of H3K9ac and p300 (Figure 4C). In good
agreement with the short half-life of the mutant NF-YA, the NF-Y
binding activity is restored 48 hours post infection. Concomitantly
we observe a strong decrease of methylated histones accompained
by a partial recovering of the p300 binding and H3K9ac levels.
Thus, the most significant event induced by loss of NF-Y binding is
an increased recruitment of closed chromatin markers, and not a
decrease of open chromatin markers. The extent of the effect of
the DN-NF-YA, both on NF-Y and chromatin marks binding, is
variable on the different tested promoters. This might depend on
the different dynamic with which the wt NF-Y trimer is replaced
by the ones carrying the mutant NF-YA protein, in the context of
the different chromatin structures of the promoters. However, the
biological effect in terms of chromatin structure and transcription
is very similar. Interestingly, the results of the Q-ChIP experiments
performed after infection with the DN-NF-YA expression vector
indicate that the heterochromatin protein HP1a does not bind
these promoters although a week recruitment is observed on cyclin
B2 promoter (Figure 4D).
The consequences of NF-YA overexpression were also evalu-
ated. For this purpose, we performed ChIP experiments in cells
infected with an adenovirus carrying the wild type NF-YA subunit
(Ad-wtNF-YA), that acts as the regulatory subunit of the trimer
[24]. The overexpression of NF-YA leads to a detectable increase
of NF-Y binding to its target promoters (Figure 4E, lane 1). This
increase was sufficient to induce hyperacetylation of histones H3
and H4 on Cyclin B2, Cdk1 and Cdc25C promoters (Figure 4E, lanes
2 and 3). Taken together, our data demonstrate that NF-Y DNA
binding activity is essential for transcription of its target genes, and
it correlates with accumulation of acetylated histones. Moreover,
lack of NF-Y binding results in lack of transcription and correlates
with the accumulation of H3K9me3 and H4K20me3 histones on
its target promoters.
Recruitment of euchromatic marks correlates with NF-Y
binding in adult tissues
To study the chromatin remodeling of NF-Y target promoters
in a physiological model system, we set up the ChIP technique on
murine muscle tissue. As assessed by RT-PCR experiments, in this
system, NF-Y target transcripts are downregulated (Figure 5A,
lane 1), as expected for a terminally differentiated tissue where the
majority of the cells should be arrested in a postmitotic status. In
good agreement with the results reported above for terminally
differentiated C2C12 cells, Figure 5B (lane 1) shows that in the
absence of NF-Y binding to its target promoters a specific
induction of methylated histones (H3K9me3 and H4K20me3) is
detectable (lanes 6 and 8, respectively), which corresponds to the
absence of the acetylated ones (H3K9ac and PAN-H4ac) (lanes 5
and 7, respectively). Thus, adult muscle tissues are characterized
by loss of NF-Y binding , concomitant accumulation of negative
and reduction of permissive marks of transcription. These features
concur to the maintenance an irreversible close chromatin
conformation of NF-Y target genes. The pattern of acetylated
and methylated histones is different if we analyze promoters that
are not regulated by NF-Y and are actively transcribed in muscle
tissues as MyoD and Myosin Light Chain (MLC). As expected, MyoD
is recruited on these promoters in vivo (Figure 5B, lane 2).
Interestingly, in this case, it is evident that acetylated histone
H3K9ac is strongly increased (lane 5), confirming an open
chromatin structure of these promoters, although H3K9me3 is
still present (lane 6). The concomitant presence of acetylated and
methylated histones H3K9 is not of obvious explanation, since
histone H3K9 cannot be simultaneously acetylated and methyl-
ated within an individual histone amino tail. It might be speculated
that different histone amino tail molecules are either acetylated or
methylated, and that the balance between these two signals will
result in the appropriate chromatin configuration. Indeed, it has
been recently demonstrated that the distribution of these two
histone marks on the promoter regions of transcriptionally active
genes overlap each other (53). The simultaneous presence of
acetylated and tri-methylated H3K9 in the same chromatin
domain might antagonize the silencing activity normally associ-
ated with H3K9 methylation.
We tested the ability of NF-Y binding in modulating the
recruitment of different modified histones onto its target DNA also
in muscle of mdx mice that represent an animal model for human
Duchenne and Becker muscular dystrophy. The muscle of mdx
mice displays a high regenerative capacity leading to muscle
hypertrophy. Interestingly, in these mice, a degeneration and
necrosis of individual fibers is accompanied by proliferation of the
satellite cells [54], providing an attractive model to investigate the
role of NF-Y in chromatin remodeling events in vivo. First, we
observed that NF-YA is expressed in the nuclei of the mdx muscle
fibers, whereas it is absent in wt muscle nuclei (Figure 5C).
Consistent with this observation, RT-PCR analysis indicate that
NF-Y target transcripts are expressed on mdx muscle tissues
(Figure 5A, lane 2). By Q-ChIP analysis (Figure 5D), performed on
five different wt and mdx mice, we found that NF-Y binds the
promoters of these genes in mdx, and that this binding is
associated with the recruitment of p300, an induction of H3K9ac
and a lack of H3K9me3 on the same promoter regions We have
previously shown that on NF-Y target promoters HDAC1
recruitment is inversely correlated to that of p300 [16]. In
agreement with this, we observed a displacement of HDAC1 from
NF-Y target promoters in mdx muscle. Loss of NF-Y binding in wt
muscle is associated with the induction of methylated H3 in
lysine9, the reduction of acetylation on the same lysine, the loss of
p300 and the recruitment of HDAC1. Notably, we confirm the
same results on two different wt mice strain (SDF1, C57BL/10).
As expected, NF-Y doesn’t bind in vivo the MLC promoter
(Figure 5E). We observed a similar level of acetylated histones onto
MLC promoter independently of the muscle tissues studied (wt
and mdx). This shows the homogeneity of the cell types
NF-Y and Chromatin Remodeling
PLoS ONE | www.plosone.org 6 April 2008 | Volume 3 | Issue 4 | e2047Figure 4. Lack of NF-Y DNA binding activity induces hypermethylation of histones and target gene inactivation. (A) RT-PCR
amplification of the indicated genes from uninfected MEFs (lane 1), MEFs 24hours after infection with Ad-GFP (lane 2), MEFs 24hours and 48hours
after infection with Ad-DN-NFYA (lanes 3 and 4). (B) Western blot analysis performed on total lysates from: Mef after 24hours post infection with Ad-
GFP (lane1), Mef after 24 hours post infection with Ad-DN-NFYA (lane 2), Mef after 48 hours post infection with Ad-DN-NFYA (lane 3). The extracts
were probed with rabbit polyclonal with anti-NFY-A. To normalised protein’s loading, the filter was stained with a monoclonal antibody anti-actin
protein. (C) Q-ChIP analysis, of the indicated NF-Y target promoters on MEF after 16, 24, 48 hours (h) from Ad-GFP (white bars), or Ad-DN-NFYA after
16 h from infection (dark grey bars), 24 h (black bars), 48 h (grey bars), performed with anti-NFY-A, -p300, -H4K20me3, -H3K9me3 and -H3K9ac
antibodies. The fold difference value in each case compares the sample performed after Ad-DN-NFYA infection to the corresponding control sample
performed after Ad-GFP infection at the same time point (defined as 1). One of two independent experiments performed in triplicate is represented.
(D) Q-ChIP analysis, performed with anti-HP1a antibody, of the indicated NF-Y target promoters on MEF after 24 h after infection with Ad-GFP (white
bars) and Ad-DN-NFYA (black bars). It is shown one of two independent experiments performed in triplicate. (E) ChIPs were performed on
proliferating MEFs 24 hours after Ad-GFP and wtNF-YA infections. No antibody was used as control (No Ab). PCR analysis were performed on the
immunoprecipitated DNA samples with anti-NFY-A, -H3K9ac and -PAN-H4ac-Pan antibodies, using specific primers for the indicate promoters.
doi:10.1371/journal.pone.0002047.g004
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PLoS ONE | www.plosone.org 7 April 2008 | Volume 3 | Issue 4 | e2047Figure 5. Recruitment of euchromatin marks correlates with NF-Y binding in adult tissues. (A) RT-PCR amplifications of indicate genes
were performed on wt and mdx murine muscle total RNAs. Aldolase and Armadillo-X-linked gene were used to normalize. (B) ChIPs performed on wt
SDF1 murine muscle tissue using the indicated antibodies. PCR were performed using specific primers for the indicated promoters. (C)
Immunohystochemical analysis of wt and mdx muscle tissue using an antibody specific for NF-YA. (D) Q-ChIP analisys of the indicate NF-Y target
promoters, performed on muscles of wt (white bars) and mdx (black bars) of C57BL/10 mice, using the indicated antibodies. (E) Q-ChIP analysis of
Myosin Light Chain (MLC) muscle specific gene, performed on muscles of wt (white bars) and mdx (black bars) of C57BL/10 mice. The results shown in
D and E are the mean of five independent experiments performed in triplicate.
doi:10.1371/journal.pone.0002047.g005
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experiments from muscle tissues.
Taken together, these results demonstrate that, also in adult
tissues in vivo, the presence of NF-Y correlates with euchromatic
markers and a mitotic status of cells. In contrast, the absence of
this transcription factor is associated with the presence of
heterochromatic markers and a postmitotic status of cells.
Discussion
As cells progress through the cell cycle and differentiation, they
must ensure that the right sections of their genomes are activated
and repressed at the appropriate times. This is achieved mainly by
regulating the dynamic association of DNA with histone and non-
histone proteins, thus by regulating chromatin structure. The
results presented in this work provide evidences that there is a
spatial relationship between newly synthesized RNA transcription-
permissive histone ‘‘code’’ and NF-Y in vivo. Consistent with this,
NF-Y DNA binding activity modulates the chromatin structure of
its target genes through the local maintenance of post-translation-
ally modified histones, resulting in gene transcription modulation.
Our ChIP data demonstrate, for the first time, that NF-Y binding
to CCAAT boxes correlates with the presence of positive (H3K9ac
and pan-H4ac) and the absence of negative (H3K9me3,
H3K27me2, H4K20me3 and HP1a) transcription marks indicat-
ing that NF-Y binding to DNA could prevent hypermethylation of
histone tails. By contrast, in the absence of NF-Y binding to
promoter of cell cycle genes, there is a substantial local recruitment
of heterochromatic markers, such as H3K9me3, H3K27me2,
H4K20me3 and HP1, known to be signals of gene silencing
[5,19,55]. Thus, we speculate here that NF-Y might influence the
balance between euchromatin and heterochromatin, regulating
active and negative histone modification marks on its target
promoters.
The significance of these findings is strongly reinforced by the
fact that we confirm our results not only in cultured and primary
cells but also in adult mice muscle tissues. Furthermore, the
biological relevance of our observations resides also in the fact that
NF-Y controls the expression of a large amount of key cell cycle
regulator genes [35,36] . Conversely, upon differentiation, the
suppression of NF-Y activity has been reported to be crucial for
the inhibition of cell cycle regulatory gene expression and the
induction of early differentiation markers [45]. Since NF-Y is
ubiquitously expressed and the cell cycle regulatory genes are
silenced in the majority of differentiated tissues, the molecular
mechanism that we describe in muscle could represents a common
pathway for cell cycle gene silencing during differentiation of
several tissues.
Our results support a model (Figure 6) in which transcription
factors, chromatin remodellers and histone modification enzymes
work together to guide the cell through cell cycle and
differentiation. According to this model, we have demonstrated
that NF-Y DNA binding activity correlates with the recruitment of
p300 and the maintenance of acetylated histones on its target
promoters (Figure 6A). These results are in agreement with
previous ones, indicating that NF-Y is required to establish a
promoter architecture that facilitate transcription [41], the pattern
of p300 binding closely matches that of NF-Y binding and
promoter activation [44], and that p300 physically interacts with
NF-Y [16, 56 55].
Our results on murine muscle tissues strongly suggest a model in
which NF-Y loss is required for heterochromatinization of cell
cycle regulatory genes and consequently represents a common
pathway for cell cycle gene silencing during differentiation
(Figure 6B). It has been previously demonstrated that the HMT
suv39h is required for myoblastic differentiation. In particular, this
protein is essential for H3K9 methylation and subsequent
repression of E2F target genes involved on G1/S transition, like
Cyclin E, Cyclin D, and Dhfr [10]. In the present paper we
demonstrate that, throughout muscle differentiation, also NF-Y
target genes are silenced by epigenetic gene regulation. Indeed, the
absence of NF-Y binding to promoters of cell cycle regulatory
genes, involved in the S/G2 and G2/M transitions, is associated
with the local enrichment of negative marks of transcription such
as H3K9me3, HP1a and H4K20me3. The recruitment of the
heterochromatic protein HP1a on NF-Y target promoters could
explain how they are irreversibly locked in a repressed state. Our
results obtained after overexpression of the DN-NF-YA and upon
terminal differentiation in vitro, demonstrate that the major event
induced by loss of NF-Y is an increase of histones methylation,
rather than a decrease of acetylation, supporting the idea that NF-
Y binding activity prevents the hypermethylation of histones,
allowing the transcription of cell cycle genes. This could mean that
the recruitment of methylated histones is sufficient to silence the
transcription of cell cycle regulatory genes, inducing an arrest of
proliferation. On the other hand, the data obtained on muscle
tissues in vivo show that the loss of NF-Y activity leads also to a loss
of acetylated histones. Therefore, these results let us to speculate
that the chromatin state of cell cycle regulatory genes might be
more permissive for transcription upon terminal differentiation in
vitro rather than in tissues in vivo. In other words, in in vitro
differentiation systems, cell cycle regulatory genes might be
‘primed’ for repression but ‘held in check’ by an opposing histone
modification. This scenario resembles the recently described
unusual ‘bivalent’ chromatin structure occurring at promoters of
master genes in ES cells, where both active and repressive
chromatin marks are physically present at the same nucleosomes
[53,57,58].
In good agreement with our data, it has been reported that
several vertebrate transcription factors involved in the cell cycle
progression recruit active marks of transcription. For example, the
recognition of Myc to its binding sites is based on specific
Figure 6. Model proposing the molecular mechanism underly-
ing the transcriptional control of cell cycle-related genes by
NF-Y.
doi:10.1371/journal.pone.0002047.g006
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enhances histone acetylation [18,59]. It has been shown that
chromatin association of activating E2F-complexes is required to
promote histone acetylation during the cell cycle [20]. Less is
known about the role of these factors in recruiting negative marks
of transcription to their target genes when the cells exit the cell
cycle and reach a postmitotic status. However, it has been recently
described that down-regulation of Myc expression leads to a
widespread decrease of active and increase of repressive chromatin
marks [60], suggesting that Myc might influence chromatin
structure of its target promoters with the same molecular
mechanism we describe here for NF-Y.
Materials and Methods
Cell culture, DNA transfection and infection, plasmids
Murine C2C12 myoblasts and HeLa cells were cultured in
DMEM supplemented with 10% FBS. Murine embryo fibroblast
(MEF) was cultured in DMEM supplemented 15% FBS. Primary
myoblasts were explanted from new-born mice andmaintained in
culture as described [50]. To avoid spontaneous differentiation,
primary satellite and C2C12 cells were never allowed to reach
confluence. Muscle differentiation was induced by plating the cells
into collagen-coated dishes and switching them for 72 h to serum
free (SF) medium. DMEM was supplemented with Redu-Ser
(Upstate Biotechnology Incorporated, Lake Placid, NY) to a final
concentration of 5 mg/ml human insulin, 5 mg/ml human (holo)
transferrin, 5 ng/ml sodium selenite. 50 mM cytosine arabinoside
(Ara-C) was added to the SF medium eliminate undifferentiated
cells. For immunofluorescent labeling and run-on, the cells were
seeded onto glass cover-slips, pretreated with L-lysine, mounted on
the bottom of 35-mm petri dishes and grown for 24 hours in
DMEM containing 10% FBS. Stable transfections were performed
as described previously [25]. The Luc-reporter constructs used in
transfection experiments was: pmutCCAAT-cyclinB2LUC [24].
Recombinant adenoviral vectors encoding DN-NF-YA, wtNF-YA
and GFP have been described previously [27]. Mouse embryo
fibroblasts were grown in DMEM containing 15% FBS and used
at 3u passage. Cells exponentially growing on plates were infected
in DMEM without serum for 1 hour at 37u C at a multiplicity of
infection (MOI) of 400. Following infection DMEM supplemented
with 15% FBS were added to each plate and the cells were
incubate at 37uC and analyzed at the indicated time-point.
Labeling of Nascent RNA (run-on)
Labeling of nascent RNA was carried out on intact living cells as
previously described [46] with some modifications. Briefly, living
cells were transfected with 3mM 5-bromouridine 59-triphosphato
(BrUTP) (Sigma-Aldrich s.r.l.) complex with the non-liposomal
transfection reagent FuGENE
TM 6 [61]. 10% of FuGENE 6 was
diluted in HEPES 20mM-saline buffer pH7.4 and incubate at
room temperature for 5 minutes. Than 3mM of BrUTP was
added to mixture and incubate for 20 minutes at room
temperature. 20–50 ml drops were transferred to cells. After
5 minutes at 4uC the coverslips were quickly washed in phosphate
buffered saline (PBS) pre-warmed to 37uC and returned to their
wells with 10% FBS medium for a pulse of 5 minutes at 37uC.
Cells were quickly fixed for 10 minutes in 2% (w/v) formaldehyde.
The BrUTP incorporated into nascent RNA was visualized by
indirect immunofluorescent labeling and the run-on efficiency was
calculated as 39% (data not shown). Control cultures treated with
FuGENE 6 only and treated with 100 ug/ml DNase-free (heated
at 95uC for 10 minutes) RNase for 30 minutes at room
temperature followed by washing and further processing for
immunofluorescence analysis, were included (data not shown).
Double Immunofluorescence labeling
Cells were fixed for 10 minutes with 2% (w/v) formaldehyde in
PBS. The following primary antibodies (diluted in 1% BSA) were
used: anti-NF-YA rabbit polyclonal (on run on experiments)
(Rockland nu200-401-100, Gilbertsville, PA), anti-NF-YA mouse
monoclonal from hybridoma cells, anti-NF-YB rabbit polyclonal
(gifts from R. Mantovani), anti-BrUTP (Roche Diagnostics
nu1170376, clone BMC 9318), anti-RPII (Santa Cruz nu 899),
anti- RPIIS2 (Abcam nu5095), anti-PAN-H4ac (Upstate nu06-
598), anti-H3ac-k9 (Abcam nu4441), anti-H3tri-m-k9 (Abcam
nu8898), anti-H4tri-m-k20 (Abcam nu9053), anti-p300 (Santa
Cruz nu 584 and 585), anti-H3di-m-k27 (Abcam nu24684) and
anti-HDAC1 (Sigma H3284). The following secondary antibodies
(diluted in 1% BSA) were used: Cy3-conjugated donkey anti-
mouse and Cy2-conjugated donkey anti-rabbit (Jackson Immu-
noResearch Laboratories). The DNA was counterstained with
0.4 mg/ml 49,6 9-diamidino-2-phenylindole (DAPI) (33258; Sigma)
(data not shown). Slides were mounted in 50% glycerol and
analyzed within 24 h. As control, the primary antibodies were
omitted (data not shown).
Confocal Scanning Laser Microscopy
All experiments were performed at least two times in duplicate.
For each experiment, 100 nuclei were visualized and at least 10
nuclei were imaged. Images were recorded by using a Zeiss LSM
510 Meta confocal laser scanning microscope equipped with a
60X/1.23 NA oil immersion objective. Ar laser (488 and 514 nm),
and HeNe laser 1 (543 nm) were used to excite the fluorophores.
Emitted fluorescence was detected with a 505- to 530-nm band-
pass filter for the green signal and a 560-nm long-pass filter for the
red signal. The LSM 510 R. 3.2 META (Zeiss) image analysis
software is used.
ChIPs and Re-ChIPs
In ChIP experiments with animals, 12 weeks old wild type
SDF1 and wt C57BL/10 and mdx mice were used. Adductor
muscles were isolated and incubated in 1.8% formaldehyde for
20 minutes at 22uC. After 5 minutes muscles were cut in small
pieces. The reaction was stopped by addition of glycine to a final
concentration of 0,125 M. Cells were incubated in 1% of
formaldehyde for 10 minutes at 22uC. The reaction was stopped
by addition of glycine to a final concentration of 0,125 M. From
this step on ChIP from cells and animal tissues have been
performed as previously described [45]. Sonicated chromatin was
incubated with 10 mg of anti-PAN-H4ac (Upstate nu06-598), -
H3ac-k9 (Abcam nu4441), -H3tri-m-k9 (Abcam nu8898), -H4tri-
m-k20 (Abcam nu9053), -HP1a (Abcam nu9057), 4 ug of anti-NF-
YA (Rockland nu200-401-100) and -p300 (Santa Cruz nu584 and
585), 4 ul of anti-HDAC1 (Sigma H3284) and 3 ug of anti-NF-YB
(gift from R. Mantovani) antibodies. In Re-ChIP experiments,
complexes were eluted by incubation for 30 minutes at 37uCi n
25 ml 10 mM DTT. After centrifugation, the supernatant was
diluted 20 times with re-ChIP buffer (1% Triton X-100, 2 mM
EDTA, 150 mM NaCl, 20 mM Tris-HCl, [pH 8.1]) and
subjected again to the ChIP procedure. For PCR and Q-PCR
analysis 2 ul of template in 20–30 ul of total reaction were used.
PCR was performed with HOT-MASTER Taq (Eppendorf). The
primers sequences of the mouse promoters were:
mCyclinA2 F59 CTGTAAGATTCCCGTCGGGCC-
TTCG,
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hCycB2 For 59- CAGAGGCGTCCTACGTCTGC
hCycB2 Rev 59-TGCGCACGGGTCGCTGTTCT
hCdk1 For 59- GAACTGTGCCAATGCTGGGA
hCdk1 Rev 59-GCAGTTTCAAACTCACCGCG





Quantitative PCR were performed using SYBR Green (Applied
Biosystems) as marker for DNA amplification, on an ABI Prism
7500 apparatus (Applied Biosystems), with 50 cycles of two-step
amplification. Each PCR reaction generates only the expected
specific amplicons, as assessed by melting-temperature profile and
by gel electrophoresis. For every promoter fragment analyzed,
each sample was quantified in triplicate from 2 to 5 independent
immunoprecipitations. On Q-PCR from animals are represented
the mean of five independent experiments performed on triplicate,
on Q-PCR from cells is shown one representative experiment
done on triplicate. The relative proportions of immunoprecipitat-
ed promoter fragments were determined based on the comparative
threshold (DCt) method (A) and relative quantification method (B)
with the same results. On the method B, a standard curve was
constructed with serial dilution of the input sample. This curve was
then used as a reference standard for extrapolating quantitative
information for ChIP sample. The equation used to calculate the
relative enrichment of the sample and no-antibody or rabbit IgG
(control) relative to input is:
X~Quantity of sample=Quantity of input
Y~Quantity of control=Quantity of input
Sample Relative Enrichment~X  Y
On the method A [17] the DCt value was calculated for each
sample (x) and for noAb or Rabbit IgG (b) by subtracting the Ct
value for the immunoprecipitated sample from the Ct value for the





DCtx~Cti  Ctx DCtb~Cti  Ctb



























RNA extraction and RT-PCR
Total RNA was extracted using the Trizol Reagent (Gibco
BRL) and following the manufacturer’s instructions. The first
strand of cDNA was synthetized according to manufacture
instructions of the M-MLV RT kit (Invitrogen). PCR was
performed with HOT-MASTER Taq (Eppendorf) using 2 mlo f
cDNA reaction. The primers sequences of the mouse genes are:
RT-mCdk1 F59GGGAATTGTGTTTTGCCACT,
RT-mCdk1 R59GATGTCAACCGGAGTGGAGT;
NF-Y and Chromatin Remodeling













RT-mAld R59-AGT GAC AGC AGG GGG CAC
TGT;
RT-Armcx2 F59 GAACTGTCTTTATCCGTCTAC,
RT-Armcx2 R59 CTGGGATCAGGAACA ATT TC.
Immunohistochemistry
Immunohistochemical staining was carried out on 5 mm thick
sections cut on SuperFrostHPlus slides (Menzel-Glaser, Menzel
GmbH & Co) from routinely formalin fixed paraffin embedded
blocks. Adductor sections from wt and MDX C57BL/10 mice,
pretreated in a thermostatic bath at 96uc for 40 minutes in 10 mM
citrate buffer (pH6.0), were processed by using l anti-NF-YA
rabbit polyclonal antibody (Rockland) and a streptavidin-biotin
immunoperoxidase system (Dako). Peroxidase activity of the
secondary antibodies was visualized by reaction with 3,39-
Diaminobenzidine (DAB) (Dako) and H2O2 in sodium phosphate
buffer.
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